英夫利西单抗血清浓度与脊柱关节炎患者感染风险的关系
该回顾性研究纳入201例以英夫利西单抗(IFX)治疗的患者,其中173例为脊柱关节炎(SpA)。在SpA患者中,随访中位1.1年期间87例发生至少1次感染事件;多变量分析显示糖皮质激素使用和IFX浓度均与首次感染风险显著相关,最高四分位浓度(>20.3 mg/L)者感染风险显著增加。
要点
- SpA患者中,IFX谷浓度最高四分位(>20.3 mg/L)者首次感染风险显著升高(HR 2.65)。
- 糖皮质激素使用与IFX浓度均独立关联首次感染事件风险(多变量P=0.004)。
- 结论需前瞻性研究验证,提示高IFX浓度可能增加感染风险。
核心结论
- 高英夫利西单抗浓度与首次感染事件风险升高相关,但需前瞻性研究重复验证。
研究设计与样本
- 回顾性纳入201例以IFX治疗批准适应症的患者,其中173例为脊柱关节炎(SpA)。
- SpA患者平均年龄46±12岁,平均病程6.2±6.1年,中位随访1.1年。
主要发现
- 87例SpA患者在随访期间发生至少1次感染事件。
- 最近3次IFX谷浓度均值低于中位数(<11.3 mg/L)者无感染生存概率显著高于高于中位数者(log-rank P=0.048)。
- 多变量分析中糖皮质激素使用和IFX浓度均与首次感染事件风险显著相关(P=0.004)。
- 最近3次IFX谷浓度均值最高四分位(>20.3 mg/L)者感染风险显著增加(HR 2.65,95%CI 1.14-6.14,P=0.023)。
关键数值与推荐
- IFX谷浓度中位数为11.3 mg/L,最高四分位阈值为20.3 mg/L。
- 感染事件定义为需住院、抗感染治疗或推迟IFX输注的首次感染。
临床怎么用
- 对SpA患者监测IFX谷浓度,尤其浓度>20.3 mg/L时需警惕感染风险。
- 合并糖皮质激素使用时应加强感染风险评估。
局限性
- 回顾性设计,样本以SpA为主,结果需前瞻性研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Tumor necrosis factor inhibitors are effective in reducing inflammation in rheumatic diseases but increase the risk of infections. This study was undertaken to investigate the relationship between the trough serum concentration of infliximab (IFX) and the risk of a first infection episode. METHODS: We retrospectively included all patients who started IFX treatment for an approved indication in our department. Patients were followed up based on recommended IFX infusion schedules. We studied the relationship between the occurrence of a first infection episode requiring hospitalization, anti-infection treatment, or IFX infusion deferral, and the last trough IFX concentration and mean of the last 3 trough IFX concentrations measured before the infection episode. RESULTS: Of the 201 patients included in the analysis, 173 had spondyloarthritis (SpA). The SpA patients had a mean ± SD age of 46 ± 12 years and a disease duration of 6.2 ± 6.1 years. During a median follow-up of 1.1 year, 87 SpA patients had at least 1 infection episode. Using Cox models, we found that the probability of survival without infection was significantly higher in patients with a mean of the last 3 trough IFX concentrations lower than the median (<11.3 mg/liter) than in patients with a mean concentration greater than the median (P = 0.048 by log-rank test). Glucocorticoid use and IFX concentration were significantly associated with the risk of a first infection episode in the multivariable analysis (P = 0.004 for both). The risk of infection episode was significantly increased in the highest quartile of the mean of the last 3 trough IFX concentrations (>20.3 mg/liter) (hazard ratio 2.65 [95% confidence interval 1.14-6.14], P = 0.023). CONCLUSION: Our findings indicate that a high IFX concentration is correlated with a higher risk of a first infection episode, but these findings need to be replicated in further prospective studies.
引用
- Bejan-Angoulvant T, Ternant D, Daoued F, et al. Brief Report: Relationship Between Serum Infliximab Concentrations and Risk of Infections in Patients Treated for Spondyloarthritis. Arthritis Rheumatol. 2016. PMID: 27894157. doi:10.1002/art.39841
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。